Evidence map›Paper›PMID 33887124›Full record

ArticleCurrent protocols2021

High-Throughput Screening of Compound Neurotoxicity Using 3D-Cultured Neural Stem Cells on a 384-Pillar Plate.

Soo-Yeon Kang, Pranav Joshi, Moo-Yeal Lee

Open access · greenAbstract read
In one paragraph

Article in Current protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Soo-Yeon KangDepartment of Chemical and Biomedical Engineering, Cleveland State University, Cleveland, Ohio.
Pranav JoshiDepartment of Chemical and Biomedical Engineering, Cleveland State University, Cleveland, Ohio.
Moo-Yeal LeeDepartment of Chemical and Biomedical Engineering, Cleveland State University, Cleveland, Ohio.
Cleveland State University · US

Funding

Mechanistic Study of Developmental Neurotoxicity on 3D Cultured Stem Cell MicroarraysR01ES025779 · NIEHS · CLEVELAND STATE UNIVERSITY · PI LEE, MOO-YEAL · 2015 to 2018
$1.3M
NIEHS NIH HHS R01 ES025779NIH HHS NIEHS R01ES025779
6 · The paper itself

Abstract

Assessing the neurotoxicity of test chemicals has typically been performed using two-dimensionally (2D)-cultured neuronal cell monolayers and animal models. The in vitro 2D cell models are simple and straightforward compared to animal models, which have the disadvantage of being relatively low throughput, expensive, and time consuming. Despite their extensive use in this area of neurotoxicology research, both models often do not accurately recapitulate human outcomes. To bridge this gap and attempt to better replicate what happens in vivo, three-dimensionally (3D) cultured neural stem cells (NSCs) encapsulated in hydrogels on a 384-pillar plate have been developed via miniature 3D bioprinting. This technology allows users to print NSCs on a pillar plate for rapid 3D cell culture as well as high-throughput compound screening. For this, the 384-pillar plate with bioprinted NSCs is sandwiched with a standard 384-well plate with growth medium for 3D culture, allowing researchers to expose the cells to test compounds and stain them with various fluorescent dyes for a suite of high-content imaging assays, including assays for DNA damage, mitochondrial impairment, cell membrane integrity, intracellular glutathione levels, and apoptosis. After acquiring cell images from an automated fluorescence microscope and extracting fluorescence intensities, researchers can obtain the IC

Indexed as

Neural Stem CellsNeurotoxicity SyndromesAnimalsCell Culture TechniquesCells, CulturedHigh-Throughput Screening AssaysHumans384-pillar platehigh-content imaging (HCI)high-throughput screening (HTS)neural stem cell (NSC)neurotoxicity

Identifiers

PMID33887124
PMCPMC8075006
OpenAlexW3153620140

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.